{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:16:26Z","timestamp":1707524186872},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,9]]},"DOI":"10.7759\/cureus.14391","type":"journal-article","created":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T20:42:41Z","timestamp":1618000961000},"source":"Crossref","is-referenced-by-count":0,"title":["Noteworthy Neurological Manifestations Associated With COVID-19 Infection"],"prefix":"10.7759","author":[{"given":"Adam C","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202001-0179LE","article-title":"Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2","volume":"202","author":"Zhao Y","year":"2020","unstructured":"Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. Am J Respir Crit Care Med. 2020, 202:756-9. 10.1164\/rccm.202001-0179LE","journal-title":"Am J Respir Crit Care Med"},{"key":"ref2","article-title":"Bell\u2019s palsy: the spontaneous course of 2500 peripheral facial nerve palsies of different etiologies","volume":"7","author":"Peitersen E","year":"2002","unstructured":"Peitersen E. Bell\u2019s palsy: the spontaneous course of 2500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl. 2002, 7:4-30.","journal-title":"Acta Otolaryngol Suppl"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.05.008","article-title":"Bell's palsy and autoimmunity","volume":"12","author":"Greco A","year":"2012","unstructured":"Greco A, Gallo A, Fusconi M, Marinelli C, Macri GF, de Vincentiis M. Bell's palsy and autoimmunity. Autoimmun Rev. 2012, 12:323-8. 10.1016\/j.autrev.2012.05.008","journal-title":"Autoimmun Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196212272672602","article-title":"The Landry-Guillain-Barre syndrome. Report of an unusual case, with a comment on Bell's palsy","volume":"267","author":"Charous DI","year":"1962","unstructured":"Charous DI, Saxe BI. The Landry-Guillain-Barre syndrome. Report of an unusual case, with a comment on Bell's palsy. N Engl J Med. 1962, 267:1334-8. 10.1056\/NEJM196212272672602","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.25.12.1154","article-title":"Cell-mediated immunity to neural antigens in idiopathic polyneuritis and myeloradiculitis. Clinical-immunologic classification of several autoimmune demyelinating disorders","volume":"25","author":"Abramsky O","year":"1975","unstructured":"Abramsky O, Webb C, Teitelbaum D, Arnon R. Cell-mediated immunity to neural antigens in idiopathic polyneuritis and myeloradiculitis. Clinical-immunologic classification of several autoimmune demyelinating disorders. Neurology. 1975, 25:1154-9. 10.1212\/wnl.25.12.1154","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510x(75)90109-4","article-title":"Cellular immune response to peripheral nerve basic protein in idiopathic facial paralysis (Bell\u2019s palsy)","volume":"26","author":"Abramsky O","year":"1975","unstructured":"Abramsky O, Webb C, Teitelbaum D, Arnon R. Cellular immune response to peripheral nerve basic protein in idiopathic facial paralysis (Bell\u2019s palsy). J Neurol Sci. 1975, 26:13-20. 10.1016\/0022-510x(75)90109-4","journal-title":"J Neurol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-198901000-00006","article-title":"Histopathology of Bell's palsy","volume":"99","author":"Liston SL","year":"1989","unstructured":"Liston SL, Kleid MS. Histopathology of Bell's palsy. Laryngoscope. 1989, 99:23-6. 10.1288\/00005537-198901000-00006","journal-title":"Laryngoscope"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-5728(96)00042-2","article-title":"Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"70","author":"Yuki N","year":"1996","unstructured":"Yuki N, Tagawa Y, Handa S. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol. 1996, 70:1-6. 10.1016\/s0165-5728(96)00042-2","journal-title":"J Neuroimmunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar JJ","year":"2011","unstructured":"Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011, 36:123-33. 10.1159\/000324710","journal-title":"Neuroepidemiology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.56.7.830","article-title":"Practice parameter: Steroids, acyclovir, and surgery for Bell's palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"56","author":"Grogan PM","year":"2001","unstructured":"Grogan PM, Gronseth GS. Practice parameter: Steroids, acyclovir, and surgery for Bell's palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001, 56:830-6. 10.1212\/wnl.56.7.830","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072006","article-title":"Early treatment with prednisolone or acyclovir in Bell's palsy","volume":"357","author":"Sullivan FM","year":"2007","unstructured":"Sullivan FM, Swan IR, Donnan PT, et al.. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med. 2007, 357:1598-607. 10.1056\/NEJMoa072006","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxx039","article-title":"IVIG-mediated effector functions in autoimmune and inflammatory diseases","volume":"29","author":"Galeotti C","year":"2017","unstructured":"Galeotti C, Kaveri SV, Bayry J. IVIG-mediated effector functions in autoimmune and inflammatory diseases. Int Immunol. 2017, 29:491-8. 10.1093\/intimm\/dxx039","journal-title":"Int Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3928\/19382359-20161213-03","article-title":"Intravenous immunoglobulin in the treatment of primary immunodeficiency diseases","volume":"46","author":"De Ranieri D","year":"2017","unstructured":"De Ranieri D, Fenny NS. Intravenous immunoglobulin in the treatment of primary immunodeficiency diseases. Pediatr Ann. 2017, 46:8-12. 10.3928\/19382359-20161213-03","journal-title":"Pediatr Ann"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/56799-noteworthy-neurological-manifestations-associated-with-covid-19-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:21Z","timestamp":1707506841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/56799-noteworthy-neurological-manifestations-associated-with-covid-19-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.14391","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,9]]}}}